OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← British Neuroscience Association Limited

2023-09-30-accounts

Registered number: 04307833 Charity number: 1103852

BRITISH NEUROSCIENCE ASSOCIATION LIMITED (A Company Limited by Guarantee)

UNAUDITED

TRUSTEES' REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

CONTENTS

Page
Reference and Administrative Details of the Charity, its Trustees and Advisers 1
Trustees' Report 2 - 16
Independent Examiner's Report 17 - 18
Statement of Financial Activities 19
Balance Sheet 20 - 21
Notes to the Financial Statements 22 - 34

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

REFERENCE AND ADMINISTRATIVE DETAILS OF THE CHARITY, ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 30 SEPTEMBER 2023

Trustees

Company registered number

04307833

Charity registered number

1103852

Registered office

Dorothy Hodgkin Building Whitson Street Bristol BS1 3NY

Company secretary

Dr L Ajram

Chief executive officer

Dr L Arjam (from June 2023)

Accountants and Independent Examiner

Martin Bailey FCA Goodman Jones LLP Chartered Accountants 29/30 Fitzroy Square London W1T 6LQ

Page 1

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2023

The Trustees present their Annual Report together with the financial statements of the Charity for the year 1 October 2022 to 30 September 2023. The Annual Report serves the purposes of both a Trustees' Report and a Directors' Report under company law. The Trustees confirm that the Annual Report and financial statements of the charitable company comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019).

Since the Charity qualifies as small under section 382 of the Companies Act 2006, the Strategic Report required of medium and large companies under the Companies Act 2006 (Strategic Report and Directors' Report) Regulations 2013 has been omitted.

Objectives and activities

a. Our vision and purpose

The BNA is a membership organisation committed to preserve and protect health and advance public engagement in neuroscience, through supporting, promoting and representing neuroscientists and neuroscience research.

b. Our objects

The Association's objects (The Objects), as formulated in the Articles of the Association (Article 4) and in the Rules of the Association (Rule 1.3), both documents coming into force in April 2017, are:

To preserve and protect health and advance public education in neurosciences related to health and disease, in particular but not exclusively) by:

All trustees had due regard to the Charity Commission's public benefit guidance when exercising powers and duties on behalf of the Charity and in determining the activities of the Charity.

Page 2

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Objectives and activities (continued)

c. Our aims

We have three interconnected aims that are central to achieving our vision and purpose, and are the means by which we deliver our objectives: these are to Inform, Connect, and Influence . The aims to Inform, Connect and Influence, were arrived at through a series of strategic workshops and engagement with members, and they help the BNA Council and Committee to direct activities throughout the year.

d. Overview of the year

2022/23 has been a year of significant change for the British Neuroscience Association following the transition of leadership and appointment of a new Chief Executive and President midway through the year.

With the support of the BNA Executive Team, Trustees and BNA members, the handover of both roles has been a success and we are taking advantage of new leadership to accelerate our growth and enter a new phase of the organisation.

Despite the inevitable disruption that change brings, the year has plenty of activities to report. Highlights include the highly successful International Festival of Neuroscience in Brighton, the BNA’s first event in the Scottish Parliament, and the continued growth and success of the BNA Scholars Programme.

As described in the following report, the impact of our activities across the year is clear and our value within the sector is increasingly recognised by the neuroscience community. This recognition is reflected in the successful growth of our network, which is now primed for engagement in activities that will hopefully drive revenue for the BNA in years to come.

The development plan for YE2024 is an ambitious plan that aims to explore new avenues of income, value for members and opportunities for the BNA to embed progress made to date, and lead us into the next phase of creating ‘an exciting and sustainable future for 21st century neuroscience’.

Page 3

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance

a. Aim 1: Inform

Scientific Journal : The Association’s scientific journal, Brain and Neuroscience Advances, is the platform through which we inform the profession about the latest neuroscience research. In November 2022, we were delighted to welcome Dr Kate Baker (University of Cambridge) to join Professor Jeff Dalley as co-Editor-in-Chief of the journal. Together with the international editorial board, their leadership and expertise continue to support our aims of widening the scope and readership of the journal.

In our ongoing commitment to fostering academic mentorship, this year we introduced a new article type called "Journal Club." This exciting addition is designed to encourage graduate students and post-doctoral researchers to actively engage with our journal by submitting their review of a recently published article. We believe this initiative will create a supportive platform for emerging scholars to contribute to the academic discourse within our field.

The number of articles published in the journal between 1st Oct 2022 – 30th Sept 2023 was as follows:

Informing members : Keeping our members informed is an essential role performed by the BNA, whether that’s informing each other about the BNA community’s ‘internal’ activities or informing them about external factors that are relevant to the field as a whole.

Our printed members’ newsletter, The BNA Bulletin, is sent out three times a year and informs members about events, prizes, news from the BNA, funders or regulators, and activities across the BNA community, as well as highlighting research undertaken by UK neuroscientists. Brain Insights is a section within the Bulletin written by and for students and Early Career Researchers, offering a valuable opportunity for early career scientists to gain writing experience.

Alongside the Bulletin members receive a monthly email newsletter, the eBulletin. This provides more frequent updates on BNA activities, jobs, events and funding.

External communications : The website and the BNA’s social media platforms are essential resources for connecting with both members and non-members. These digital communication channels make the BNA readily accessible to members of the public, and the office often receives enquiries from journalists, patients and prospective students.

During 2022–2023 the website attracted 97.4k users and 354k page views. This compares to 161.6k users and 459k page views in the period 2021–2022. The website needs upgrading to improve the user-friendly credentials e.g. rendering well on mobile devices. This will increase the engagement and traffic to the BNA website.

By the end of this reporting period, the BNA had 36.8k (X / Twitter), 15.4k (Facebook), 18.7k (LinkedIn), 3.9k (Instagram) and 3.4k (YouTube) followers, respectively. This represents an overall increase in our followers across our social media channels.

Public engagement of neuroscience : ‘Bring Your Own Brain’ (BYOB), our public engagement partner programme to the International Festival of Neuroscience, took place over two months (March-–April 2023) in and

Page 4

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

around Brighton. Organised by the University of Sussex, BYOB comprised over 20 events and activities for all age groups, including:

Page 5

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

b. Aim 2: Connect

Connecting the neuroscience community through BNA membership : over the course of YE2023 we saw membership make a modest but important increase from 2,621 to 2,653 (+32). To put this increase in context, the table below shows membership trends over the previous 3 years:

In 2023 we saw modest increases across all membership types (with the exception of Early Career Researchers). The increases in Full and Full (Industry) members come as a result of the efforts both of the local recruitment efforts of Local Group Representatives in institutions across the country (see below) and the Building Bridges Between (BBB) initiative which is successfully beginning to position the BNA as the organisation through which neuroscientists from academia, industry, and the clinic can connect and collaborate. The increases in Associate and Retired members reflects the success of the 2023 Festival of Neuroscience’s public engagement programme (see above), as well as the continued strengthening of the BNA’s wider reputation as an authority on neuroscience.

BNA Local Groups : The BNA has a national network of Local Groups (LGs) each headed by a Local Group Representative (LGR). Many groups also have one or more Local Group Student Representatives (LGSRs). In YE2023, the number of Local Groups increased from 39 to 44.

LGRs provide a point of contact for members of a Local Group to access a number of member benefits within the BNA. For example, any applications for Local Group funding are made through the LGRs. In 2022-23, £8,294 was granted to 20 BNA Local Groups to deliver local events for their members. 11 of these Local Groups took advantage of additional funding via a ‘post-COVID booster’ scheme, implemented in 2023 to encourage uptake of the funding following reduced in person events during the COVID period.

LG activities for which funding was awarded during YE2023 are listed below – some of these events will take place in YE2024:

Page 6

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

In September 2023, the LGRs and LGSRs met in Manchester for the annual Local Group Forum (featuring a special session on teaching priorities led by LGSRs), and the online monthly meetings of LGRs have also continued. The connection to members via the Local Groups scheme remains a valuable way of engaging with our members to explore opportunities that are of value to the community.

Connecting with industry (‘Building Bridges Between: Industry and Academia’ (BBB)) : The BNA's sustained efforts in cultivating relationships with the commercial sector have yielded substantial financial gains and impactful partnerships. Going into YE2024, we now have access to a broad network of organisations and influential figures who can contribute to BNA activities, engage in collaborative projects, and invest in our events, including the International Festival of Neuroscience. We have elevated awareness of the critical role industry plays in advancing neuroscience in the UK, broadened the scope of activities to our membership and supported meaningful scientific exchange.

The BNA is now primed to play a pivotal role in convening different sectors under a common goal. In November 2022 the joint symposium, ‘New treatments in pain and how to meet them’ brought together key players from Industry (Eli Lilly), Medical Research Charity (Versus Arthritis), and Academia (University of Sheffield). Through our annual theme (Artificial Intelligence), we led a Hackathon together with Arca Blanca and DDM Health to convene our academic members with digital health companies to drive new ways of enhancing healthcare and digital education interventions.

BNA Meetings : Bringing people together via events is essential for the BNA to fulfil its aim to connect. Through our meetings we enable neuroscientists to connect with each other, across disciplines and geographies, and goes towards meeting our object to “disseminate information to all those interested in the neurosciences and related disciplines”.

During this reporting period we held the 6th International Festival of Neuroscience at the Brighton Centre on the UK’s south-eastern coast. Following an online festival in 2021 (due to Covid-19) this was the first in-person festival in four years (since Dublin, 2019).

22 Partner Organisations joined the BNA to deliver a highly successful festival, which attracted 1,216 participants from 32 countries (75% of delegates were from the UK and Ireland). 65 organisations supported the festival through partnerships and exhibitions.

The BNA awarded £13,308.60 in bursaries and awards at the festival, the highest number to date. Awards included:

In addition to the festival, we held a number of online and in person meetings during the reporting period,

Page 7

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

including:

In addition to a series of credibility in neuroscience events (see Aim 3 below).

Membership of societies : The BNA is a member of three organisations which make sure the BNA membership is part of a larger voice. Membership of the Royal Society of Biology (RSB) connects us with all the life sciences across the UK. The Federation of European Neuroscience Societies (FENS) enables the BNA and BNA members to be part of European neuroscience, and membership of the International Brain Research Organisation (IBRO) connects the BNA with the global community.

Of the three organisations, the BNA is most actively involved in FENS. The BNA is a member of the FENS Governing Council, and was represented at FENS meetings through the year.

Page 8

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

c. Aim 3: Influence

As the largest UK-based organisation representing neuroscience and neuroscientists, the BNA is in position to influence the sector, decision-makers, and neuroscientists themselves. Having influence is central in fulfilling two of the Association’s objects: (c) Advising as far as possible on issues in neurosciences related to health and disease; and (f) Representing the interests of neuroscience researchers and promoting the case for the advancement of neuroscience research in the United Kingdom to government, to agencies providing research funding and to bodies engaged in science administration, regulation and standards.

Our main areas of activity in the area of ‘influence’ are listed below.

Credibility in Neuroscience : We are now four years into our core campaign to, “support the neuroscience sector to increase the transparency, reproducibility, replicability and reliability of neuroscience research”. Some key achievements during the reporting period include:

Westminster enquiry into research reproducibility: In May 2023, the BNA's proposed recommendations from the previous year were notably incorporated into the final report of the Commons Science, Innovation, and Technology Committee's reproducibility inquiry. Specifically, the Committee endorsed several of our suggestions, recommending that:

Credibility in Neuroscience events: Credibility was a key theme of the BNA2023 Festival of Neuroscience, with an opening plenary panel session and the announcement of the 2023 Credibility Prize Winners. Pre-registration posters also featured prominently at the Festival, with an increased proportion compared against the last inperson BNA festival (BNA2019). Additionally, for the first time, poster submitters were able to apply for ‘Open Science badges’ and a new ‘Open Science Poster Prize’ was awarded alongside our existing poster prizes, to acknowledge open science practices.

Additional Credibility in Neuroscience events in YE2023 included -

BNA journal, Brain and Neuroscience Advances: Our journal is one of only a handful of journals worldwide to cover the full range of open science practices – being Gold Open Access, offering Registered Reports, CRediT taxonomy, Transparency and Openness Promotion (TOP) Guidelines and Badges for Open Practices.

Promoting credibility: We continue to encourage our network of research funders and neuroscience organisations to promote Credibility in Neuroscience and implement credible practices into their activities and are beginning to see uptake of this by the community – for instance, at our recommendation, preregistration

Page 9

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

posters were introduced for the first time at the 2023 Scottish Neuroscience Group annual meeting.

Contributing our expertise externally: We are now recognised as pivotal advocate for changes in practice to promote credibility. As a result, we were invited to join as a stakeholder member the iRISE project, funded by Horizon Europe to understand, investigate and guide strategies to address irreproducibility in research. We attended the project’s kick-off meeting at the Berlin Institute for Health in September 2023.

Equity, diversity and inclusion (EDI) in neuroscience : The role the BNA has in this space continues to grow, and the Association is committed to influencing and increasing EDI in our sector.

Our most significant activity is the ongoing management and growth of the BNA Scholars Programme. In YE2023, the programme welcomed a further 7 Scholars to support a total of 21 students and Early Career Researchers from under-represented ethnic groups to flourish in neuroscience. Support for the programme also grew and we welcomed ABPI, MSD and the University of Sussex's School of Neuroscience to our Scholar Supporters Network. Our growing network enabled us to provide a diverse range of career development opportunities for the Scholars. Scholars attended 11 events over the reporting period, including conferences, site visits to labs and headquarters and CV surgeries. We are grateful to our Supporters for hosting and enabling these events and career development opportunities.

Additionally, to ensure our events are accessible to all, we continue to award ‘Carer Grants’ (supported by the Guarantors of Brain) which enable those with caring responsibilities to participate in neuroscience activities by e.g. paying for childcare or help for elderly relatives.

A voice in UK Parliaments : The BNA is a member of the Parliamentary and Scientific Committee (P&SC). This committee is an interface between scientists and parliamentarians and provides opportunities for the BNA to inform decision-making that takes place in both the House of Commons and the House of Lords, and enables us to raise awareness of issues that we feel are important for neuroscientists. The BNA was represented at P&SC meetings throughout the year.

In June 2023, the BNA held its first event at the Scottish Parliament. The event, sponsored by Daniel Johnson MSP, highlighted the importance of neuroscience research in addressing Scotland’s health challenges of the future. Attended by MSPs from various political parties, the event spurred a motion in Holyrood which was signed by 29 MSPs, including Scottish Labour leader Anas Sarwar MSP. The event facilitated new connections with influential organisations such as the Royal Society of Edinburgh, the Neurological Alliance of Scotland, and the Neurosciences Foundation. Moreover, it served as an initial platform to engage with MSPs for future collaborations.

The BNA also highlighted the role of Scottish neuroscience in a Westminster inquiry into Science and Scotland held by the House of Commons Scottish Affairs Committee, submitting written evidence in September 2023.

Green neuroscience: In December 2022, we introduced a new ‘Train over Plane’ grant to reduce the carbon footprint of travel to BNA events – further supporting our members to engage with our Green Neuroscience campaign. Our efforts to deliver sustainable events is now recognised globally – Louise Tratt, Head of Meetings and Events, was selected as the winner of the ‘2023 C&IT Corporate A-lister Award’ and invited to give talks on BNA sustainability in events in York (UK) and Boston (USA).

Animals in Research: The BNA continues to be committed to openness on the use of animals in research and is a signatory of the Concordat on Openness on Animal Research in the UK. We are an active member of the RSB’s Animal Science Group (a special interest group representing the broad spectrum of UK bodies actively involved in supporting, funding, or formulating policy on research involving animals), and the UK Bioscience Sector Coalition (which represents the collective views of the bioscience sector with an interest in the use of animals in research). In November 2022, the BNA responded to a consultation by the Animals in Science

Page 10

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Achievements and performance (continued)

Committee (ASC) on the Forced Swim Test (FST). Our response highlighted the important role of the FST in the development of new treatments for mental health conditions and understanding behavioural responses to stress. In July 2023, the ASC’s final report recommended against discontinuing the FST but advised it should not serve as a model of depression. This mirrored our stance and there are indications our input directly influenced the ASC's recommendations, affirming the tangible impact of our policy and advocacy work.

BNA prizes : Winners of the BNA’s annual prizes in YE2023 were as follows:

Financial review

a. Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements. Further details regarding the adoption of the going concern basis can be found in the Accounting Policies.

b. Financial review

During the financial year ending 30th September 2023 the BNA’s total income was £322,934 (2022: £407,416). Expenditure, which was wholly on charitable activities to advance education in neuroscience, was £364,725 (2022: £319,236); after taking account of net gains on investments, the net movement in funds was a deficit of £11,791 (2022: £54,121 surplus).

The net reserves carried forward was £585,940 (2022: £597,731). Of this, around £118,960 (2022: £85,502) is held in restricted funds, committed largely to (1) delivering activities associated with funding from the Gatsby Charitable Foundation, and (2) supporting the BNA’s equity, diversity and inclusion work.

Funding has and will continue to be used to support the BNA Trustees’ ten-year strategic plan, in particular the ‘Credibility in Neuroscience’ campaign, but also other activities which meet the aims to ‘Inform, Connect and Influence’.

The BNA remains is in a stable financial position to sustain itself and to meet its charitable objectives.

Page 11

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

c. Reserves policy

The BNA’s reserves policy states that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to one year’s expenditure, where one year’s expenditure is calculated on the basis of:

The Trustees consider that reserves at this level will ensure that, in the event of a significant drop in revenue, they will be able to continue the Association’s current activities while consideration is given to ways in which additional funds may be raised and/or costs can be reduced. The level of this reserve will be maintained throughout the course of each accounting year.

The reserves policy will be reviewed in YE2024.

d. Principal funding

The main sources of income for the BNA in 2023 were membership subscriptions of £106,391 (2022: £101,222) and grants and donations of £215,144 (2022: £207,701), which includes £160,000 from The Gatsby Charitable Foundation.

e. Investment policy and objectives

The Trustees’ investment powers are governed by Article 5 in the Articles of Association. This permits the Charity to deposit or invest funds in securities or property as may be thought fit in order to further its Objects, or is conducive or incidental to doing so, subject to conditions and consents as laid down in the Association’s governing documents.

The Trustees’ policy for YE2024 will be to continue to optimise income on temporarily invested funds and to maintain a balanced portfolio of long-term investments, and continue to manage the Charity’s investments in conformity with our policy and Trust Deed.

Structure, governance and management

a. Constitution

British Neuroscience Association Limited is a company limited by guarantee, as defined by the Companies Act 2006. The Company is registered as a charity under the registration number 1103852.

The BNA is governed by its Memorandum and Articles of Association, and accompanying set of Rules. No changes have been made to governing articles since 2017.

Page 12

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Structure, governance and management (continued)

b. Organisational structure

The British Neuroscience Association is a membership organisation, with seven membership categories (defined in the Rules), plus a number of Honorary members. With the exception of Associate members, all members have voting rights on the principle of “one member, one vote”, which is exercised at the Annual General Meetings (detailed in Articles 15-27).

The Association has 44 Local Groups (Rule 5), that provide for a national network between members and the Association’s governance team.

The BNA is governed by a Council of Trustees, comprising between seven and twelve members of the Association (Article 29). Non-Trustee positions on the Council include the Meetings Secretary, other co-opted members for specific functions and other invited observers or advisors. The specific procedures for the appointment and retirement of the Trustees are detailed in the Articles (32-35).

To help with discharging the activities of the Association, the BNA has also a National Advisory Committee (formerly “The National Committee”) whose role is to represent different demographics and interests within the Association’s membership (Rule 4).

Supporting all activities and needs of the Council, Committee, and general membership is the BNA Executive. During the year this consisted of two full time and three part-time staff members.

c. Risk management

The Trustees have a duty to identify and review the risks to which the Charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error. Potential risks, once identified, will be monitored and controlled to mitigate any impact that they may have on the Association in the future.

To help with this the BNA has a Risk Register. Conflict of Interest (Rules 8 and 9) and a Register of Interests. BNA has a specific Declaration of Interests form, that is completed by all members of the Council and Committee of the BNA.

Page 13

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Plans for future periods

The strategic pillars of the BNA remain ‘Inform, Connect, Influence’, with the ‘Credibility in Neuroscience’ continuing as our core 5-10 year commitment underlying all our activities.

At the start of YE2024, key priorities are as follows:

CONNECT: Engaging our membership and connecting the community

In 2024, we will engage our members at the local and national levels and communicate the value of BNA membership. We will invest in our membership management systems, our team and our marketing and communications activities to ensure the membership and our Local Groups are supported and that our brand and communications are professional and targeted to our members interests.

To reflect our ambition to connect the wider neuroscience community, we will expand our ‘Building Bridges Between Industry and Academia’ activities to encompass all sectors, including research charities, foundations, patient groups, clinicians, small and large industry, biotech and medtech. We will explore value propositions for each group, to better understand how the BNA can support each sector and develop activities that will drive engagement with new groups.

INFORM: Professionalising the sector

We will continue to explore opportunities to set the standard of neuroscience higher education in the UK via the accreditation of taught neuroscience courses. Additionally, we will explore the potential of running our own, BNA-led training courses to provide value for our members, an opportunity to engage non-members in other sectors (in particular clinicians) and an additional income stream for the organisation.

For our early career and student members in particular, we will provide career development opportunities and connections to support those embarking on their professional careers in neuroscience.

INFLUENCE: Policy, Advocacy and Credibility

As a British organisation, we recognise the importance of working with members across the British Isles and not focusing our policy and advocacy efforts on Westminister. Following the success of our event in the Scottish Parliament in 2023, we will host an event in Wales in 2024, to engage with our Welsh members and the Welsh Parliament.

Initiatives under the Credibility in Neuroscience campaign will continue, and we will begin to explore our next campaign with our members. The BNA has built a strong reputation with our Credibility work, we will leverage this to create opportunities to engage with new groups of stakeholders, potential members, and supporters.

Page 14

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Reference and administrative details

Members of BNA Council

appointed April 2021 elected March 2023 elected May 2022 appointed April 2021 appointed April 2021 elected May 2020 elected May 2022 elected May 2022 elected May 2022 appointed April 2017 appointed April 2017 appointed April 2017 appointed October 2021 appointed September 2023

Members of the National Committee

Elected April 2023 Elected June 2020 Appointed May 2022 Appointed May 2022

Executive

Page 15

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Statement of Trustees' responsibilities

The Trustees (who are also the directors of the Charity for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Charity and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Charity's transactions and disclose with reasonable accuracy at any time the financial position of the Charity and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Approved by order of the members of the board of Trustees and signed on their behalf by:

................................................

Professor T L Spires-Jones Chair

Date: 28-05-24

Page 16

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 30 SEPTEMBER 2023

Independent Examiner's Report to the Trustees of British Neuroscience Association Limited ('the Charity')

I report to the charity Trustees on my examination of the accounts of the Charity for the year ended 30 September 2023.

Responsibilities and Basis of Report

As the Trustees of the Charity (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Charity are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Charity's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent Examiner's Statement

Since the Charity's gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of Institute of Chartered Accountants in England and Wales, which is one of the listed bodies.

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

  1. accounting records were not kept in respect of the Charity as required by section 386 of the 2006 Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fair' view which is not a matter considered as part of an independent examination; or

  4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)].

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

This report is made solely to the Charity's Trustees, as a body, in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Charity's Trustees those matters I am required to state to them in an Independent Examiner's Report and for no other purpose. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than the Charity and the Charity's Trustees as a body, for my work or for this report.

Page 17

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

INDEPENDENT EXAMINER'S REPORT (CONTINUED) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Signed:

Dated: 28-05-24

Martin Bailey FCA Goodman Jones LLP 29/30 Fitzroy Square London W1T 6LQ

Page 18

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 30 SEPTEMBER 2023

Note
Income from:
Donations and legacies
4
Charitable activities
5
Investments
6
Total income
Expenditure on:
Charitable activities
7
Total expenditure
Net (expenditure)/income before net
gains/(losses) on investments
Net gains/(losses) on investments
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
2023
£
16,376
106,391
1,399
124,166
199,415
199,415
(75,249)
30,000
(45,249)
512,229
(45,249)
466,980		 Restricted
funds
2023
£
198,768
-
-
198,768
165,310
165,310
33,458
-
33,458
85,502
33,458
118,960		 Total
funds
2023
£
215,144
106,391
1,399
322,934
364,725
364,725
(41,791)
30,000
(11,791)
597,731
(11,791)
585,940		 Total
funds
2022
£
207,701
101,222
98,493
407,416
319,236
319,236
88,180
(34,059)
54,121
543,610
54,121
597,731

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 22 to 34 form part of these financial statements.

Page 19

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee) REGISTERED NUMBER: 04307833

BALANCE SHEET AS AT 30 SEPTEMBER 2023

Note
Fixed assets
Tangible assets
11
Investments
12
Current assets
Debtors
13
Cash at bank and in hand
Creditors: amounts falling due within one
year
14
Net current assets
Total assets less current liabilities
Total net assets
Charity funds
Restricted funds
15
Unrestricted funds
15
Total funds		 20,509
215,993
236,502
(11,438)		 2023
£
1,656
359,220
360,876
225,064
585,940
585,940
118,960
466,980
585,940		 57,722
229,129
286,851
(19,693)		 2022
£
1,353
329,220
330,573
267,158
597,731
597,731
85,502
512,229
597,731

The Charity was entitled to exemption from audit under section 477 of the Companies Act 2006.

The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006.

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

Page 20

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

BALANCE SHEET (CONTINUED) AS AT 30 SEPTEMBER 2023

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

................................................

Professor T L Spires-Jones Chair

Date: 28-05-24

The notes on pages 22 to 34 form part of these financial statements.

Page 21

BRITISH NEUROSCIENCE ASSOCIATION LIMITED (A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

1. General information

British Neuroscience Association Limited is a Charitable Company Registered in England and Wales. The registered office address is Dorothy Hodgkin Building, Whitson Street, Bristol BS1 3NY.

The Charity is a company limited by guarantee. The members of the company are the Trustees named on page 1. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the Charity.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

British Neuroscience Association Limited meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

The financial statements are prepared in sterling, which is the functional currency of the Charity. Monetary amounts in these financial statements are rounded to the nearest £.

2.2 Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Charity has adequate resources to continue in operational existence for the foreseeable future. The Trustees have considered the future plans of the Charity and expected income, and it is deemed that the Charity can meet its commitments and liabilities and can continue for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Charity and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Charity for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 22

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

2. Accounting policies (continued)

2.4 Income

All income is recognised once the Charity has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service. Membership fees are recongised in the period to which they relate.

Grant income is recognised when the Charity has entitlement to the funds, any performance conditions attached to the grants have been met, it is probable that the income will be received, and the amount can be measured reliably.

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Charity; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.6 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Charity's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

All expenditure is inclusive of irrecoverable VAT.

2.7 Tangible fixed assets and depreciation

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Page 23

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

2. Accounting policies (continued)

2.7 Tangible fixed assets and depreciation (continued)

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Computer equipment

2.8 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of Financial Activities.

Investments in subsidiaries are valued at cost less provision for impairment.

2.9 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.10 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.11 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Charity anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

2.12 Financial instruments

The Charity only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

Page 24

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

2. Accounting policies (continued)

2.13 Pensions

The Charity operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Charity to the fund in respect of the year.

3. Critical accounting estimates and areas of judgement

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

The Charity makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. No estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year have been identified.

4. Income from donations and legacies

Donations
Total 2022		 Unrestricted
funds
2023
£
16,376
4,558		 Restricted
funds
2023
£
198,768
203,143		 Total
funds
2023
£
215,144
207,701		 Total
funds
2022
£
207,701

5. Income from charitable activities

Subscriptions and Bulletin advertising
Total 2022		 Unrestricted
funds
2023
£
106,391
101,222		 Total
funds
2023
£
106,391
101,222		 Total
funds
2022
£
101,222

Page 25

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

6. Investment income

Unrestricted
funds
2023
£
Dividend income
-
Bank interest
1,399
Total 2023
1,399
Total 2022
98,493		 Total
funds
2023
£
-
1,399
1,399
98,493		 Total
funds
2022
£
98,275
218
98,493

7. Analysis of expenditure on charitable activities Summary by fund type

Advance education in neuroscience
Total 2022		 Unrestricted
funds
2023
£
199,415
149,939		 Restricted
funds
2023
£
165,310
169,297		 Total
2023
£
364,725
319,236		 Total
2022
£
319,236

8. Analysis of expenditure by activities

Advance education in neuroscience
Total 2022		 Activities
undertaken
directly
2023
£
203,948
209,517		 Support
costs
2023
£
160,777
109,719		 Total
funds
2023
£
364,725
319,236		 Total
funds
2022
£
319,236

Page 26

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

8. Analysis of expenditure by activities (continued)

Analysis of direct costs

Advance
education in
neuroscience
2023
£
Staff costs
115,164
Bulletin production
27,860
Bursaries and sponsorship
-
Gatsby project costs
33,031
Subscriptions and membership
10,103
Advertising
4,790
Travel
7,256
Printing, postage and stationery
45
Telephone
675
Journal production
5,024
Total 2023
203,948
Total 2022
209,517		 Total
funds
2023
£
115,164
27,860
-
33,031
10,103
4,790
7,256
45
675
5,024
203,948
209,517		 Total
funds
2022
£
126,108
24,513
8,151
34,692
7,556
1,600
1,653
768
-
4,476
209,517

Page 27

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

8. Analysis of expenditure by activities (continued)

Analysis of support costs

Staff costs
Depreciation
Advertising
Travel
Printing, postage and stationery
Telephone
Website development
Professional fees
Insurance
Bank charges
Sundry
Governance
Bad debt
Total 2023
Total 2022		 Advance
education in
neuroscience
2023
£
111,711
701
3,622
7,682
123
816
1,992
7,637
1,161
16,842
4,472
3,888
130
160,777
109,719		 Total
funds
2023
£
111,711
701
3,622
7,682
123
816
1,992
7,637
1,161
16,842
4,472
3,888
130
160,777
109,719		 Total
funds
2022
£
82,735
450
866
6,727
110
600
3,872
7,693
1,090
2,825
751
2,000
-
109,719

Governance costs include independent examination fees of £2,500 (2022: £2,000).

9. Staff costs

Wages and salaries
Social security costs
Contribution to defined contribution pension schemes		 2023
£
201,553
16,025
9,297
226,875		 2022
£
185,282
14,850
8,711
208,843

Page 28

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

9. Staff costs (continued)

The average number of persons employed by the Charity during the year was as follows:

2023 2022
No. No.
Employees 5 6
No employee received remuneration amounting to more than £60,000 in either year.
Total remuneration, including employer's national insurance and pension contributions, in respect of key
management personnel totalled £57,524 (2022: £58,717).

10. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2022 - £NIL) .

During the year ended 30 September 2023, no Trustee expenses have been incurred (2022 - £NIL to 0 Trustees ) .

11. Tangible fixed assets

Cost or valuation
At 1 October 2022
Additions
At 30 September 2023
Depreciation
At 1 October 2022
Charge for the year
At 30 September 2023
Net book value
At 30 September 2023
At 30 September 2022		 Office
equipment
£
4,355
1,005
5,360
3,002
702
3,704
1,656
1,353

Page 29

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

12. Fixed asset investments

Cost or valuation
At 1 October 2022
Revaluations
At 30 September 2023
Net book value
At 30 September 2023
At 30 September 2022
Principal subsidiaries
The following was a subsidiary undertaking of the Charity:
Name
Company
number
BNA Events Limited
07784689
The financial results of the subsidiary for the year were:
Name
BNA Events Limited		 Investments
in
subsidiary
companies
Other
investments
Total
£
£
£
100
329,120
329,220
-
30,000
30,000
100
359,120
359,220
100
359,120
359,220
100
329,120
329,220
Class of
shares
Holding
Included in
consolidation
Ordinary
100% Yes
Profit/(Loss)
for the year
£
Net assets
£
116,643
158,264		 Total
£
329,220
30,000
359,220
359,220
329,220

Page 30

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

13. Debtors

Due within one year
Trade debtors
Amounts owed by group undertakings
Other debtors
Prepayments and accrued income		 2023
£
(256)
14,254
-
6,511
20,509		 2022
£
13,342
41,742
11
2,627
57,722

14. Creditors: Amounts falling due within one year

Trade creditors
PAYE and social security
Other creditors
Accruals and deferred income		 2023
£
-
-
3,438
8,000
11,438		 2022
£
5,962
1
-
13,730
19,693

Page 31

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

(A Company Limited by Guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

15. Statement of funds

Statement of funds - current year

Unrestricted funds
General Funds - all funds
Restricted funds
Wolstencroft fund
Journal fund
Gatsby Charitable Foundation
Guarantors of Brain
Equity, diversity and inclusion
(EDI)
Total funds		 Balance at 1
October
2022
£
512,229
6,500
300
51,077
9,792
17,833
85,502
597,731		 Income
£
124,166
-
4,920
160,000
5,000
28,848
198,768
322,934		 Expenditure
£
(199,415)
-
(5,024)
(132,903)
(2,797)
(24,586)
(165,310)
(364,725)		 Gains/
(Losses)
£
30,000
-
-
-
-
-
-
30,000		 Balance at
30
September
2023
£
466,980
6,500
196
78,174
11,995
22,095
118,960
585,940

Page 32

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

15. Statement of funds (continued)

Statement of funds - prior year

Unrestricted funds
General Funds - all funds
Restricted funds
Wolstencroft fund
Journal fund
Gatsby Charitable Foundation
Guarantors of Brain
Equity, diversity and inclusion
(EDI)
Total funds		 Balance at
1 October
2021
£
491,954
6,500
-
35,364
9,792
-
51,656
543,610		 Income
£
204,273
-
4,776
150,000
-
48,367
203,143
407,416		 Expenditure
£
(149,939)
-
(4,476)
(134,287)
-
(30,534)
(169,297)
(319,236)		 Gains/
(Losses)
£
(34,059)
-
-
-
-
-
-
(34,059)		 Balance at
30
September
2022
£
512,229
6,500
300
51,077
9,792
17,833
85,502
597,731

Restricted funds comprise the following:

Wolstencroft fund - for expenses in regard to a lecture on ‘Outstanding Neuroscience’ at the biennial BNA Festival.

Journal fund - for editing and general running of the journal.

Gatsby Charitable Foundation - to support the implementation of the BNA's new strategic plan.

Guarantors of Brain - funding for Equity, diversity and inclusion (EDI) in neuroscience education.

Equity, diversity and inclusion (EDI) - funding to support Equity, diversity and inclusion (EDI) in neuroscience education.

Page 33

(A Company Limited by Guarantee)

BRITISH NEUROSCIENCE ASSOCIATION LIMITED

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 SEPTEMBER 2023

16. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2023
£
Tangible fixed assets
1,656
Fixed asset investments
359,220
Current assets
117,542
Creditors due within one year
(11,438)
Total
466,980		 Restricted
funds
2023
£
-
-
118,960
-
118,960		 Total
funds
2023
£
1,656
359,220
236,502
(11,438)
585,940

Analysis of net assets between funds - prior year

Tangible fixed assets
Fixed asset investments
Current assets
Creditors due within one year
Total		 Unrestricted
funds
2022
£
1,353
329,220
198,488
(16,832)
512,229		 Restricted
funds
2022
£
-
-
88,363
(2,861)
85,502		 Total
funds
2022
£
1,353
329,220
286,851
(19,693)
597,731

17. Pension commitments

The Charity operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Charity in an independently administered fund. The pension cost charge represents contributions payable by the Charity to the fund and amounted to £9,297 (2022: £8,711). Contributions of £968 (2022: £nil) were owed to the fund at the balance sheet date.

18. Related party transactions

At the balance sheet date, British Neuroscience Association Limited was owed £14,254 (2022: £41,742) by BNA Events Limited, its wholly-owned subsidiary.

Other than disclosed above or elsewhere in these financial statements, there were no other transactions with related parties requiring disclosure.

Page 34